Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Budget alignment ensures every dollar spent serves your priorities, keeping resources directed toward meaningful gains.
20,933 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
The FDA confirms a national shortage of needles used detect breast after a recall. Hospitals warn the gap could delay...
The Federal Reserve holds rates steady, but new chair Kevin Warsh’s hawkish cues spurred a late-day market pullback. ...
Alphabet blew past expectations with a robust earnings beat and a cloud backlog that leapt to $460 billion, signaling...
Zillow sues Compass and MRED, followed by a study and survey, signaling a calculated communications strategy designed...
A bold claim about a $22.7 trillion enterprise AI opportunity could reshape portfolios. This piece breaks down the th...
A political move surrounding a major AI stock has sparked a market spike and ethics questions. This report analyzes t...
The memory market has reshaped profits for chip makers and device companies. This article explains how Micron benefit...
Claude Guillemot, a co-founder who built Ubisoft into a global gaming brand, died in a plane crash near La Baule, Fra...
Oil prices surged after Iran closed the Strait of Hormuz again, renewing inflation concerns and pressuring Fed policy...
A major Ethereum Layer-2 network, Taiko, halted block production after an exploit. Blockaid suggests the root cause l...
Bitmine has purchased 52,203 ETH for roughly $90 million, boosting its stake to about 4.7% of ETH's circulating suppl...